Alzheimer Disease
MDS Nordion Enters Collaboration Agreement with Avid Radiopharmaceuticals on Imaging Compounds for Alzheimer's Disease
Published in Telemedicine Law Weekly, April 21st, 2007
MDS Nordion, a leading global provider of medical isotopes and radiopharmaceuticals used in molecular medicine, has entered into a collaboration agreement with Avid Radiopharmaceuticals Inc. to support clinical studies for Avid's novel radiopharmaceuticals designed to diagnose and monitor Alzheimer's disease. These trials will use advanced molecular imaging known as single photon emission computed tomography (SPECT). Under the terms of the agreement, MDS Nordion will radiolabel Avid's proprietary compounds for use in proof-of-concept clinical trials for SPECT imaging of Alzheimer's disease.
Avid is a pioneer in the development of radiopharmaceuticals for imaging...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Telemedicine Law Weekly
More Articles from Telemedicine Law Weekly
- Abdominal Pain Quality of Care
Research conducted at Baylor College of Medicine has updated our knowledge about abdominal pain quality of care - Alzheimer Disease
PharmAthene's Recombinant Butyrylcholinesterase (rBChE) Program the Subject of Promising New Alzheimer's Research - Amyloidosis
Investigators at Copenhagen University, Department of Radiology publish new data on amyloidosis - Analytical Chemistry
New analytical chemistry data have been reported by researchers at Virtual Institute of Microbial Stress and Survival - Analytical Chemistry
New analytical chemistry study findings have been reported by researchers at Arizona State University - Analytical Chemistry
New analytical chemistry study findings have been reported by scientists at Fudan University, Department of Chemistry - More from this issue of Telemedicine Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
